Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients
Clinical trial NCT01546571 · TERMINATED
Trial details
- NCT number
- NCT01546571
- Sponsor
- Polynoma LLC
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2021-04-29
- Enrollment
- 504
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.